ASCL1 and NEUROD1 Reveal Heterogeneity in Pulmonary Neuroendocrine Tumors and Regulate Distinct Genetic Programs

Cited by papers we hold 17

• Tumor- and circulating-free DNA methylation identifies clinically relevant small cell lung cancer subtypes · 2024
  No notice
• Emerging therapies targeting the delta-like ligand 3 (DLL3) in small cell lung cancer · 2023
  No notice
• A human fetal lung cell atlas uncovers proximal-distal gradients of differentiation and key regulators of epithelial fates · 2022
  No notice
• Notch signaling pathway: architecture, disease, and therapeutics · 2022
  No notice
• Heterogeneity of neuroendocrine transcriptional states in metastatic small cell lung cancers and patient-derived models · 2022
  No notice
• ASCL1 activates neuronal stem cell-like lineage programming through remodeling of the chromatin landscape in prostate cancer · 2022
  No notice
• Reprogramming of the FOXA1 cistrome in treatment-emergent neuroendocrine prostate cancer · 2021
  No notice
• Molecular profiles of small cell lung cancer subtypes: Therapeutic implications · 2021
  No notice
• Subtype heterogeneity and epigenetic convergence in neuroendocrine prostate cancer · 2021
  No notice
• Pathology and Classification of SCLC · 2021
  No notice
• Detection and characterization of lung cancer using cell-free DNA fragmentomes · 2021
  No notice
• DLL3: an emerging target in small cell lung cancer · 2019
  No notice
• Integrative genomic profiling of large-cell neuroendocrine carcinomas reveals distinct subtypes of high-grade neuroendocrine lung tumors · 2018
  No notice
• Recurrent WNT pathway alterations are frequent in relapsed small cell lung cancer · 2018
  No notice
• Lung Cancers: Molecular Characterization, Clonal Heterogeneity and Evolution, and Cancer Stem Cells · 2018
  No notice
• Dynamic variations in epithelial-to-mesenchymal transition (EMT), ATM, and SLFN11 govern response to PARP inhibitors and cisplatin in small cell lung cancer · 2017
  No notice
• Reciprocal expression of INSM1 and YAP1 defines subgroups in small cell lung cancer · 2017
  No notice

Reads

A person counts once a day per paper. We keep no cookie and no address: a reader is a hash that changes every day. Any month under five reads shows no number.